From: The Role of Diffusion Weighted Imaging in suspected cases of ovarian cancer
Ovarian lesions subtypes | |||
---|---|---|---|
Malignant | NB (%) | Benign | NB (%) |
*Primary ovarian tumors | Serous cystadenoma | 7 (13.7%) | |
High-grad papillary serous | 6 (11.7) | Mature teratoma | 3 (5.9%) |
Low-grade papillary serous | 4 (7.8% | Mucinous cystadenoma | 3 (5.9%) |
Mucinous adenocarcinoma | 1 (1.9%) | Fibrothecoma | 3 (5.9%) |
Endometrioid adenocarcinoma | 1 (1.9%) | Fibroma | 2 (3.9%) |
Malignant germ cell tumor | 2 (3.9%) | Endometrioid cystadenoma | 1 (1.9%) |
Malignant granulosa cell | 1 (1.9 %) | Endometrioidcystadenofibroma | 1 (1.9%) |
Malignant endodermal sinus tumor | 1 (1.9%) | Endometriosis with abscess | 2 (3.9%) |
*Metastatic ovarian tumors | Tubo-ovarian abscess | 4 (7.8%) | |
Endometrial cancer | 2 (3.9%) | Necrotizing caseating granuloma | 1 (1.9%) |
Uterine leiomyosarcoma | 1 (1.9%) | Infarcted ovary | 1 (1.9%) |
Colon adenocarcinoma | 2 (3.9%) | ||
Gastric carcinoma | 1 (1.9%) | ||
Malignant mesothelioma | 1 (1.9%) |